Bitting Kurt
Known title: See RemarksCIK: 0001769761
Bitting Kurt's purchase track record
How the stock did after each of Bitting Kurt's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 4 since May 12, 2022
Stock higher 6 months later
100%
3 months: 75%
Median 6-month return
+13.2%
3 months: +4.8%
Beat the S&P 500
75%
median +5.1% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/5/2024 | ECVT | $31K | +20.9% | +22.0% | +15.6% |
| 8/23/2023 | ECVT | $30K | +1.1% | +1.6% | +12.3% |
| 8/5/2022 | ECVT | $95K | +8.5% | +23.5% | -0.2% |
| 5/12/2022 | ECVT | $50K | -1.9% | +4.3% | +0.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ECVT | ▲ Buy | Option Exercise | 38,064 | $116K | 3/12/2026 | View on chart |
| ECVT | ▼ Sell | Tax Withholding | 25,925 | $267K | 2/3/2026 | View on chart |
| ECVT | ▲ Buy | Grant | 116,392 | $0 | 2/3/2026 | View on chart |
| ECVT | ▼ Sell | Tax Withholding | 16,053 | $174K | 1/22/2026 | View on chart |
| ECVT | ▼ Sell | Tax Withholding | 16,097 | $158K | 1/5/2026 | View on chart |
| ECVT | ▲ Buy | Grant | 154,044 | $0 | 2/3/2025 | View on chart |
| ECVT | ▼ Sell | Tax Withholding | 14,315 | $114K | 1/22/2025 | View on chart |
| ECVT | ▼ Sell | Tax Withholding | 27,060 | $210K | 1/5/2025 | View on chart |
| ECVT | ▲ Buy | Open Market | 5,000 | $31K | 8/5/2024 | View on chart |
| ECVT | ▲ Buy | Grant | 99,319 | $0 | 1/22/2024 | View on chart |
| ECVT | ▼ Sell | Tax Withholding | 30,705 | $290K | 1/5/2024 | View on chart |
| ECVT | ▲ Buy | Open Market | 3,100 | $30K | 8/23/2023 | View on chart |
| ECVT | ▼ Sell | Tax Withholding | 63,032 | $717K | 7/1/2023 | View on chart |
| ECVT | ▲ Buy | Grant | 12,306 | $0 | 3/8/2023 | View on chart |
| ECVT | ▼ Sell | Tax Withholding | 1,359 | $15K | 3/8/2023 | View on chart |
| ECVT | ▼ Sell | Tax Withholding | 714 | $7K | 1/20/2023 | View on chart |
| ECVT | ▲ Buy | Grant | 106,708 | $0 | 1/16/2023 | View on chart |
| ECVT | ▼ Sell | Tax Withholding | 13,362 | $121K | 1/5/2023 | View on chart |
| ECVT | ▲ Buy | Open Market | 10,750 | $95K | 8/5/2022 | View on chart |
| ECVT | ▲ Buy | Open Market | 5,144 | $50K | 5/12/2022 | View on chart |
| ECVT | ▲ Buy | Grant | 24,335 | $0 | 3/1/2022 | View on chart |
| ECVT | ▼ Sell | Tax Withholding | 1,917 | $20K | 3/1/2022 | View on chart |
| ECVT | ▼ Sell | Tax Withholding | 496 | $5K | 1/20/2022 | View on chart |
| ECVT | ▲ Buy | Grant | 72,887 | $0 | 1/17/2022 | View on chart |
| ECVT | ▲ Buy | Grant | 145,773 | $0 | 1/17/2022 | View on chart |
| ECVT | ▼ Sell | Tax Withholding | 4,163 | $43K | 1/5/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Ecovyst draws attention in bargain stock and EV/EBITDA screens
Ecovyst was featured in two recent Zacks selection lists, including a roundup of bargain stocks and a separate screen highlighting companies with notable EV-to-EBITDA ratios. Separately, former chief accounting officer Patti Humble was noted for joining the Exceptional Women Alliance, an industry-network recognition rather than a company event. The Zacks mentions point to valuation-based interest in ECVT, while its RSI near 39 and a well-tested support level around $12.80 provide additional context for the recent price action.
Ecovyst draws attention in bargain stock and EV/EBITDA screens. Ecovyst was featured in two recent Zacks selection lists, including a roundup of bargain stocks and a separate screen highlighting companies with notable EV-to-EBITDA ratios. Separately, former chief accounting officer Patti Humble was noted for joining the Exceptional Women Alliance, an industry-network recognition rather than a company event. The Zacks mentions point to valuation-based interest in ECVT, while its RSI near 39 and a well-tested support level around $12.80 provide additional context for the recent price action.